Oncotarget | Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma
“High prevalence of surface GPC3 makes it a putative drug target.” Credit: Muralidharan et al. “High prevalence of surface GPC3 ...